Literature DB >> 24698175

Expression of cancer-related carbonic anhydrases IX and XII in normal skin and skin neoplasms.

Leo Syrjänen1, Tiina Luukkaala, Mari Leppilampi, Matti Kallioinen, Silvia Pastorekova, Jaromir Pastorek, Abdul Waheed, William S Sly, Seppo Parkkila, Tuomo Karttunen.   

Abstract

Purpose of the study was to evaluate the presence of hypoxia-inducible, tumour-associated carbonic anhydrases IX and XII in normal skin and a series of cutaneous tumours. Human tumour samples were taken during surgical operations performed on 245 patients and were immunohistochemically stained. A histological score value was calculated for statistical analyses which were performed using SPSS for Windows, versions 17.0 and 20.0. In normal skin, the highest expression of CA IX was detected in hair follicles, sebaceous glands, and basal parts of epidermis. CA XII was detected in all epithelial components of skin. Both CA IX and CA XII expression levels were significantly different in epidermal, appendigeal, and melanocytic tumour categories. Both CA IX and XII showed the most intense immunostaining in epidermal tumours, whereas virtually all melanocytic tumours were devoid of CA IX and XII immunostaining. In premalignant lesions, CA IX expression significantly increased when the tumours progressed to more severe dysplasia forms. Both CA IX and XII are highly expressed in different epithelial components of skin. They are also highly expressed in epidermal tumours, in which CA IX expression levels also correlate with the dysplasia grade. Interestingly, both isozymes are absent in melanocytic tumours.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CA IX; CA XI; skin; skin neoplasm

Mesh:

Substances:

Year:  2014        PMID: 24698175     DOI: 10.1111/apm.12251

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  6 in total

1.  The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.

Authors:  Céline Pinheiro; Vera Miranda-Gonçalves; Adhemar Longatto-Filho; Anna L S A Vicente; Gustavo N Berardinelli; Cristovam Scapulatempo-Neto; Ricardo F A Costa; Cristiano R Viana; Rui M Reis; Fátima Baltazar; Vinicius L Vazquez
Journal:  Cell Cycle       Date:  2016-04-22       Impact factor: 4.534

2.  Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer.

Authors:  Dong-Bin Wang; Xi-Ke Lu; Xun Zhang; Zhi-Gang Li; Cai-Xia Li
Journal:  Tumour Biol       Date:  2015-08-01

3.  Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.

Authors:  Daniela Pucciarelli; Nina Lengger; Martina Takacova; Lucia Csaderova; Maria Bartosova; Heimo Breiteneder; Silvia Pastorekova; Christine Hafner
Journal:  Int J Oncol       Date:  2015-05-18       Impact factor: 5.650

4.  Switching the Inhibitor-Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII.

Authors:  Joana Smirnovienė; Alexey Smirnov; Audrius Zakšauskas; Asta Zubrienė; Vytautas Petrauskas; Aurelija Mickevičiūtė; Vilma Michailovienė; Edita Čapkauskaitė; Elena Manakova; Saulius Gražulis; Lina Baranauskienė; Wen-Yih Chen; John E Ladbury; Daumantas Matulis
Journal:  ChemistryOpen       Date:  2021-05       Impact factor: 2.630

5.  Novel therapeutic compound acridine-retrotuftsin action on biological forms of melanoma and neuroblastoma.

Authors:  Miroslawa Cichorek; Anna Ronowska; Monika Gensicka-Kowalewska; Milena Deptula; Iwona Pelikant-Malecka; Krystyna Dzierzbicka
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-26       Impact factor: 4.553

Review 6.  Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities.

Authors:  René G Feichtinger; Roland Lang
Journal:  J Oncol       Date:  2019-11-03       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.